earnings

What You'll Want to Know About Myriad Genetics' Disappointing Q4 Results
Motley Fool
Wed, 08/14/19 - 10:59 am
Myriad Genetics
earnings
Elanco Animal Health Beats Q2 Earnings Estimates but Faces Increasing Headwinds
Motley Fool
Tue, 08/13/19 - 04:37 pm
Elanco Health
earnings
animal health
AnaptysBio Prepares for a Potential Gear Shift
Yahoo/Motley Fool
Sun, 08/11/19 - 01:25 pm
AnaptysBio
earnings
etokimab
Novo Nordisk's new diabetes, obesity drugs lift sales outlook
Yahoo/Reuters
Fri, 08/9/19 - 10:33 am
Novo Nordisk
earnings
Nektar Therapeutics stock drops after results
Marketwatch
Thu, 08/8/19 - 11:39 pm
Nektar Therapeutics
earnings
Here's Why Puma Biotechnology Fell 24.1% in July
Motley Fool
Wed, 08/7/19 - 11:51 pm
Puma Biotechnology
earnings
Celgene Continues Growing While Waiting for its Acquisition to Close
Motley Fool
Wed, 08/7/19 - 10:55 am
Celgene
earnings
M&A
Bristol-Myers Squibb
BioMarin's Roller Coaster Continues
Yahoo/Motley Fool
Tue, 08/6/19 - 11:00 am
Biomarin
earnings
Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand
Yahoo/Reuters
Tue, 08/6/19 - 10:54 am
Allergan
earnings
Abiomed Is Still in the Recovery Ward
Motley Fool
Sun, 08/4/19 - 01:05 pm
Abiomed
earnings
Impella RP
devices
Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates
Yahoo/Zacks.com
Fri, 08/2/19 - 11:46 pm
Bluebird Bio
earnings
Boehringer posts solid first half as business revamp beds in
PM Live
Fri, 08/2/19 - 11:44 pm
Boehringer Ingelheim
earnings
Spiriva
Jardiance
Acadia, Neurocrine See Stock Price Bump After Quarterly Earnings
Xconomy
Fri, 08/2/19 - 12:55 pm
earnings
Acadia
Neurocrine
Crysvita sales push Ultragenyx ahead for the quarter
BioCentury
Fri, 08/2/19 - 12:24 am
Ultragenyx
Crysvita
earnings
Amarin boosted as another milestone to the FDA’s big Vascepa decision flies by with no sign of an AdCom
Endpoints
Wed, 07/31/19 - 10:30 am
FDA
Amarin
Vascepa
advisory panels
earnings
Celgene Offers Beat-And-Raise As Bristol Merger Looms Closer
Investors Business Daily
Wed, 07/31/19 - 08:50 am
Celgene
earnings
M&A
Bristol-Myers Squibb
Amgen results beat estimates, lung cancer trial planned
Yahoo/Reuters
Wed, 07/31/19 - 08:49 am
Amgen
earnings
clinical trials
lung cancer
AMG510
Gilead Sciences Reports Improving Revenue in the 2nd Quarter
Motley Fool
Wed, 07/31/19 - 08:47 am
Gilead Sciences
earnings
Biktarvy
Neurocrine Biosciences Posts Sizzling Sales Growth in Q2
Motley Fool
Tue, 07/30/19 - 07:58 am
Neurocrine Biosciences
earnings
Merck profit beats on strong demand for Keytruda, vaccines
Yahoo/Reuters
Tue, 07/30/19 - 07:56 am
Merck
earnings

Pages